Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ot: ESCL...I think I'm going to cry
If S&L are converting warrents and selling, as we suspect, then PTSC s/b buying and continue to buy at these price levels. As long as this situation with S&L continues, it is to the shareholders benefit that the pps remains attractive for buy back. My hope is the 10% of revs min for buy back is just that - A MINIMUM and in fact they are buying substantially more than that, because IMHO that is what PTSC should be doing. That 10% minimun is from memory, please correct me if that is a misstatement on my part.
Share
New Message
Please login to post a reply